• Mouse Neutrophil Cell Isolation Kit: Assay Design

  2026-08-12

  The Mouse Neutrophil Cell Isolation Kit supports high-purity, activation-conscious preparation for functional assays. This article explains how source selection, negative selection, and assay controls shape interpretation in neutrophil-targeted immunotherapy research.

• Anlotinib hydrochloride: Angiogenesis Workflows

  2026-08-11

  Learn how to use Anlotinib hydrochloride to connect receptor-level inhibition with endothelial migration, tube formation, and ERK pathway readouts. This workflow-focused guide also shows how the compound can support translational cancer research while avoiding common assay and interpretation errors.

• Bazedoxifene for Reproducible Cell Assays

  2026-08-11

  This scenario-driven guide explains how Bazedoxifene, SKU A3232, can support controlled estrogen receptor, proliferation, and viability experiments. It covers mechanism, solvent handling, concentration design, data interpretation, and practical vendor-selection criteria using product data and current literature.

• Dicoumarol Targets IRE1α in ER Stress Liver Injury

  2026-08-10

  Yang and colleagues developed a screening workflow that combined molecular docking, an XBP1s activity reporter, flow cytometry, and mouse liver-injury models to identify dicoumarol as an inhibitor of IRE1α signaling. The study links target-oriented screening with protection against tunicamycin- and carbon tetrachloride-induced hepatic endoplasmic reticulum stress, while also clarifying the limitations of translating an acute model into broader liver disease research.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-08-09

  Saito and colleagues established a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be propagated, cryopreserved, and converted into intestinal epithelial monolayers with enterocyte-associated metabolic and transporter activities, providing a more human-relevant platform for oral drug pharmacokinetic research.

• 2-APB as a Calcium Pathway Deconvolution Probe

  2026-08-08

  2-APB (2-aminoethoxydiphenyl borate) is more than a calcium-release blocker: it can help separate IP3R- and TRPC-dependent signals in mechanistic assays. This article connects calcium perturbation design with the PLCβ3–Gαq cardiovascular pathway while defining practical controls, limitations, and interpretation strategies.

• 7ACC2: MCT1 Inhibitor for Cancer Metabolism

  2026-08-07

  7ACC2 is a nanomolar monocarboxylate transporter 1 inhibitor for dissecting lactate flux, pyruvate use, and tumor radiosensitization. This workflow-focused guide shows how to combine transport assays, metabolic profiling, immune-context experiments, and troubleshooting controls without confusing MCT1 blockade with mitochondrial pyruvate transport inhibition.

• URB597 (KDS-4103): Precision FAAH Inhibition for Pain Circui

  2026-08-07

  Explore how URB597, a potent FAAH inhibitor, uniquely enables high-fidelity dissection of endocannabinoid signaling in pain and neuroinflammation models. This article offers a deeper, protocol-driven perspective on neurocircuit modulation, bridging advanced mechanistic insight with practical research applications.

• Rotigotine hydrochloride: Experimental Workflows and PD Rese

  2026-08-06

  Rotigotine hydrochloride stands out as a versatile dopamine D2/D3 receptor agonist, enabling sophisticated modeling of Parkinson’s disease, depression, and neurodegenerative processes. This article details applied workflows, troubleshooting strategies, and practical insights for maximizing reproducibility and translational relevance with Rotigotine hydrochloride from APExBIO.

• Verteporfin (CL 318952): Mechanisms, Assay Innovation, and C

  2026-08-06

  Discover how Verteporfin (CL 318952) advances photodynamic therapy and autophagy inhibition, with new scientific insights on overcoming chemoresistance. This article explores unique mechanistic pathways and practical assay decisions for age-related macular degeneration and beyond.

• Imipenem in Translational Research: Mechanisms, Resistance,

  2026-08-05

  This article delivers a thought-leadership perspective on deploying Imipenem, a semisynthetic thienamycin antibiotic, to address the rising challenge of multidrug-resistant infections. We bridge molecular insights, experimental best practices, and strategic guidance for translational researchers. Drawing on recent advances in resistance gene transmission studies, this piece synthesizes protocol design, competitive landscape analysis, and forward-looking outlooks for antibacterial research—escalating the discussion beyond standard product descriptions or laboratory troubleshooting guides.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Use G

  2026-08-05

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) addresses the critical need to prevent proteolytic degradation during protein extraction and sample preparation, especially where preservation of phosphorylation states or divalent cation-dependent activities is necessary. This product is recommended for workflows such as Western blotting, kinase assays, and co-immunoprecipitation, but is not suitable for protocols requiring EDTA-based metalloprotease inhibition. Use only as directed to avoid interference with DMSO- or cation-sensitive steps.

• Small Molecule Optimization Boosts Pancreatic Ductal Organoi

  2026-08-04

  This study presents a new protocol using a small molecule cocktail to significantly enhance the efficiency and stability of pancreatic ductal organoid generation. The resulting model faithfully recapitulates ductal and acinar cell populations, providing a high-fidelity platform for pancreatic disease research and drug screening.

• Aging, Mitochondrial ROS, and Collagen: Mechanisms of Impair

  2026-08-04

  This study uncovers how aging impairs macrophage phagocytosis by linking mitochondrial ROS-driven collagen overproduction to defective actin dynamics. The findings highlight actionable molecular mechanisms for restoring immune cell function in aged organisms, with implications for targeted interventions in immune aging.

• Triptolide (PG490): Precision Control in Translational Resea

  2026-08-03

  Triptolide (PG490) stands at the intersection of mechanistic insight and translational opportunity, offering researchers a nanomolar-potency tool to interrogate transcriptional regulation, inhibit cancer invasion, and modulate immune responses. This article explores the biological rationale underpinning triptolide's utility, presents experimental benchmarks, and provides strategic guidance for deploying this transcriptional inhibitor in cancer and immunology models. Drawing on recent advances in genome activation research and referencing the latest findings from Xenopus laevis developmental biology, we spotlight how triptolide enables high-fidelity, reproducible workflows that move beyond conventional product summaries. Protocol recommendations, competitive positioning, and a forward-looking outlook round out this comprehensive resource for translational researchers.

14582 records 1/973 page Next 12345 下5页 Last page